Work

Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa

Year: 2006

Type: article

Study design: Observational Study

Source: JAMA

DOI: 10.1001/jama.295.3.293

Author: Kathryn A. O’Connell

Institutions: Center for Biologics Evaluation and Research, United States Food and Drug Administration

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2140699529

FWCI: 57.87

Cites: 8

Cited by: 664

Related to: 10